CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVS

Phase 3

Development Phase

4

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
NVSPhase 2

Ianalumab Phase 2 Est. Readout

Ianalumab
Q3 2027~Q
CT.gov
00%
Q2 '27
NVSPhase 3

ianalumab Phase 3 Est. Readout

Ianalumab
Q2 2027~Q
CT.gov
00%
Mar '27
NVSPhase 3

Ianalumab Phase 3 Est. Readout (SIRIUS-SLE 1)

Ianalumab
Mar 2027~
CT.gov
00%
Oct '26
NVSPhase 3

ianalumab Phase 3 Est. Readout

Ianalumab
Oct 2026~
CT.gov
00%
Competitive Landscape

1 competitor in Warm Autoimmune Hemolytic Anemia (wAIHA)

View Full Landscape
Drug Information

Target Indication

Warm Autoimmune Hemolytic Anemia (wAIHA)

Clinical Trial

NCT05648968

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.